Ash Stevens

Riverview, United States Founded: 1962 • Age: 64 yrs Acquired By Piramal Group
Small-molecule drug development and cGMP manufacturing services are offered.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Ash Stevens

Ash Stevens is a company based in Riverview (United States) founded in 1962 was acquired by Piramal Group in August 2016. Ash Stevens operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.

  • Headquarter Riverview, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Piramal Group

    (Aug 16, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Ash Stevens

Premium access

Detailed funding history for Ash Stevens

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Ash Stevens

Ash Stevens has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Piramal Group.

All
Institutional
Investor Description Founded Year Domain Location
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
Locked Locked Locked
Premium access

Investor details for Ash Stevens

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Ash Stevens

Investments
Premium access

Investment portfolio details for Ash Stevens

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Ash Stevens

Premium access

Detailed financials for Ash Stevens

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ash Stevens Comparisons

Ash Stevens Primary company
Description
Small-molecule drug development and cGMP manufacturing servi...
Location
Riverview, United States
Founded Year
1962
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Ash Stevens

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Ash Stevens

Ash Stevens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Integrated CDMO services for biopharma R&D and manufacturing are offered.
Locked Locked Locked
APIs manufacturing and formulation services are provided in therapeutic segments.
Locked Locked Locked
APIs and enzymes are manufactured through fermentation by the CDMO.
Locked Locked Locked
APIs and finished products are developed and manufactured.
Locked Locked Locked
Generic biocatalytic solutions are provided for pharmaceutical applications.
Locked Locked Locked
APIs and peptides are developed and manufactured by Asymchem.
Premium access

Detailed competitors of Ash Stevens

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ash Stevens

Premium access

Complete news archive for Ash Stevens

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ash Stevens

Ash Stevens was founded in 1962.

Ash Stevens is headquartered in Riverview, United States. It is registered at Riverview, Florida, United States.

Ash Stevens was founded in 1962 and is located in Riverview, United States. Operations focus on the pharmaceutical sector as a contract development and manufacturing organization (CDMO). Small-molecule drug substance development, cGMP manufacturing of high-potency active pharmaceutical ingredients (HPAPIs) and APIs, analytical support including method development and validation, and regulatory compliance services are provided from early-stage to commercial production.

Ash Stevens's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.

Ash Stevens has 1 investor. Key investors include Piramal Group.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available